SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is facing significant volatility as investors weigh a strong earnings beat and raised full-year guidance against the sudden departure of its CFO and persistent fears that AI-driven shifts could threaten its long-term market position. While many community members are treating the dip as a prime value opportunity, citing robust cash flow and aggressive share buybacks, others are wary of the stock potentially becoming a 'value trap' amidst a broader rotation out of established software names.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is trending as traders speculate on its potential as a strategic partner to SpaceX, with social media discourse heavily split between optimism over its additive manufacturing role in rocket production and skepticism regarding its recent financial performance, high valuation, and dilution history.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing intense investor interest ahead of the upcoming mid-month BlueBird satellite launch, with the community closely tracking its progress as a key pure-play competitor in the direct-to-device cellular market. The stock is being bolstered by the broader space-sector momentum surrounding a major upcoming IPO, while shareholders remain focused on the company's partnerships with top-tier mobile carriers and expanding government defense contracts.

Virgin Galactic Holdings, Inc. is an aerospace and space travel company, which engages in the provision of consumer space experience using reusable spaceflight systems. The firm is also involved in designing, developing, and manufacturing, ground and flight testing, spaceflight operation, and post-flight maintenance of spaceflight systems. The company was founded on May 5, 2017 and is headquartered in Tustin, CA.

Virgin Galactic Holdings Inc - Ordinary Shares - Class A

Virgin Galactic Holdings Inc

Virgin Galactic is surging on extreme volume as retail investors trade it as a high-beta proxy and speculative 'proxy' for the highly anticipated SpaceX IPO. The community is actively debating the potential for a massive short squeeze while speculating whether ticker confusion will drive further retail inflows and momentum.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending as investors digest its official inclusion in the Nasdaq-100, which is driving significant institutional interest and fueling speculation about a potential supply squeeze. The community is actively debating the stock's role as a public pure-play alternative to the highly anticipated SpaceX IPO, with many discussing the impact of forced index fund buying versus short-term volatility as retail traders navigate sector-wide shifts.

Tema ETF Trust - Tema Space Innovators ETF

Tema Space Innovators ETF

The Tema Space Innovators ETF is trending as investors aggressively position themselves ahead of the upcoming SpaceX IPO, with the community actively debating whether the fund provides a strategic advantage or if the sector faces a volatility-induced shakeout. While many traders see the fund as a rare vehicle for pre-IPO exposure, discussions are dominated by concerns over potential post-IPO selling pressure and the broader market's sensitivity to space sector momentum.

Entrepreneurshares Series Trust - ERShares Private-Public Crossover ETF

XOVR is trending as investors seek exposure to the highly anticipated SpaceX IPO, with the community actively debating its strategy of blending concentrated public innovation holdings with significant, direct private exposure to SpaceX. While some investors are concerned about the fund's price action and portfolio structure compared to other space-focused assets, many are accumulating shares, viewing it as an accessible, liquid vehicle for long-term growth in the space sector.

Astera Labs, Inc. is a global semiconductor company, which engages in the provision of hardware and software solutions for AI and cloud infrastructure applications to solve data, memory, and networking bottlenecks. It operates through the following geographical segments: Taiwan, China, United States, and Other. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Astera Labs is surging after investors reacted positively to management's updates at the J.P. Morgan conference regarding their Scorpio X-Series and increased focus on optical networking to address AI data center connectivity bottlenecks. Community sentiment remains highly bullish, with many investors highlighting the stock's strong relative strength and institutional accumulation while debating the sustainability of its current valuation.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is attracting significant attention as investors speculate on potential government-backed investments and large-scale nuclear energy contracts. The community is actively discussing the stock's volatility and its role in meeting the massive energy demands of AI data centers, while balancing optimism over project catalysts against frustration with recent price consolidation.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is currently in the spotlight following the official announcement of its inclusion in the Nasdaq-100 index, a major catalyst expected to drive significant passive index fund demand and institutional visibility. While the community is actively debating the stock's long-term valuation and the impact of ongoing insider share sales, sentiment remains sharply divided between those viewing the index upgrade as a structural liquidity magnet and those concerned about the company's debt levels and management's selling activity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Iovance Biotherapeutics, Inc. (IOVA) a Top Penny Stock to Buy on Amtagvi Strong Adoption

Iovance Biotherapeutics, Inc. (IOVA) a Top Penny Stock to Buy on Amtagvi Strong Adoption...

IBRX Stock Outlook After Q1 Results and a New FDA Review

ImmunityBio eyes a steadier path after a 290% YTD surge as investors watch Anktiva demand, FDA review timing and execution risks.

ImmunityBio: Anktiva Explained and What Comes Next

IBRX's Anktiva drives a 668% revenues jump in 2025 as ImmunityBio expands bladder cancer approvals and pursues new catalysts.

AGEN vs. IOVA: Which Cancer Biotech Stock Has More Upside Potential?

Iovance's commercial momentum and expanding Amtagvi pipeline make it appear better positioned than Agenus despite higher valuation.

IOVA Q1 Earnings Match Estimates, Sales Miss, Stock Down 13%

Iovance matches Q1 earnings estimates, but weaker-than-expected Amtagvi and Proleukin sales sent shares down 13% despite revenue growth.

Why Is IOVA Stock Falling Today?

Equity

During the first quarter, Iovance posted a 45% increase in revenue to $71.4 million, which came in below Wall Street’s estimates of $75.6 million, according to Fiscal.ai data.

Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Lags Revenue Estimates

Iovance Biotherapeutics (IOVA) delivered earnings and revenue surprises of 0.00% and -7.36%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Alvotech (ALVO) Reports Q1 Loss, Lags Revenue Estimates

Alvotech (ALVO) delivered earnings and revenue surprises of -28.57% and -22.19%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Ultragenyx (RARE) Reports Q1 Loss, Misses Revenue Estimates

Ultragenyx (RARE) delivered earnings and revenue surprises of -18.96% and -15.66%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Iovance Biotherapeutics (NASDAQ:IOVA) Shares Up 6.3% - Still a Buy?

Iovance Biotherapeutics (NASDAQ:IOVA) Trading 6.3% Higher - Here's What Happened...

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Current Price	$3.96
Prev Close	$3.78
Open	$3.78
Dividend Yield	0.00%
50-Day Moving Average	$3.72
Beta	1.76
Avg. Volume	15.67M
PE Ratio	-4.17

52-Week High	$5.63
52-Week Low	$1.66
Market Capitalization	$1.69B
EPS (Annual)	-$1.09
Price to Book	2.40
Revenue Per Employee	$270,258.46

IOVAIovance Biotherapeutics Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IOVA News